Funding for this research was provided by:
AstraZeneca Canada (ESR-16-12361)
Received: 23 August 2018
Accepted: 2 January 2019
First Online: 14 January 2019
Ethics approval and consent to participate
: The proposed study has been approved by the Centre Hospitalier de l’Université de Montreal IRB.
: Not applicable.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.